(VIANEWS) – RPC (RES), STAAR Surgical Company (STAA), Magellan Midstream Partners L.P. Limited Partnership (MMP) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. RPC (RES)
33.3% sales growth and 29.12% return on equity
RPC, Inc., through its subsidiaries, provides a range of oilfield services and equipment for the oil and gas companies involved in the exploration, production, and development of oil and gas properties. The company operates through Technical Services and Support Services segments. The Technical Services offers pressure pumping, fracturing, acidizing, cementing, downhole tools, coiled tubing, snubbing, nitrogen, well control, wireline, pump down, and fishing services that are used in the completion, production, and maintenance of oil and gas wells. The Support Services segment provides a range of rental tools, including blowout preventors, high pressure manifolds and valves, hevi-wate drill pipes, tubing products, production related rental tools, pumps, diverters, drill pipes, drill collars, handling tools, Coflexip hoses, and Wear Knot drill pipes that are used for onshore and offshore oil and gas well drilling, completion, and workover activities. This segment also offers oilfield pipe inspection, and pipe management and storage services; and oilfield training and consulting services. It operates in the United States, Africa, Canada, Argentina, China, Mexico, Eastern Europe, Latin America, the Middle East, and internationally. RPC, Inc. was founded in 1984 and is headquartered in Atlanta, Georgia.
Earnings Per Share
As for profitability, RPC has a trailing twelve months EPS of $1.01.
PE Ratio
RPC has a trailing twelve months price to earnings ratio of 9.16. Meaning, the purchaser of the share is investing $9.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.12%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
RPC’s EBITDA is 1.44.
2. STAAR Surgical Company (STAA)
28.2% sales growth and 12.58% return on equity
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, and Italy. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Earnings Per Share
As for profitability, STAAR Surgical Company has a trailing twelve months EPS of $0.12.
PE Ratio
STAAR Surgical Company has a trailing twelve months price to earnings ratio of 602.17. Meaning, the purchaser of the share is investing $602.17 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.58%.
Yearly Top and Bottom Value
STAAR Surgical Company’s stock is valued at $72.26 at 05:22 EST, way below its 52-week high of $112.27 and way above its 52-week low of $46.36.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 8.3% and 20%, respectively.
Moving Average
STAAR Surgical Company’s value is way above its 50-day moving average of $62.48 and higher than its 200-day moving average of $70.98.
Revenue Growth
Year-on-year quarterly revenue growth grew by 30%, now sitting on 261.65M for the twelve trailing months.
3. Magellan Midstream Partners L.P. Limited Partnership (MMP)
10.2% sales growth and 49.42% return on equity
Magellan Midstream Partners, L.P. engages in the transportation, storage, and distribution of refined petroleum products and crude oil in the United States. The company operates through Refined Products, Crude Oil, and Marine Storage segments. It operates refined products pipeline that transports gasoline, distillates, aviation fuels, and liquefied petroleum gases for independent refiners and integrated oil companies, wholesalers, retailers, traders, railroads, airlines, bio-fuel producers, and regional farm cooperatives; and provides services, including terminalling, ethanol and biodiesel unloading and loading, additive injection, custom blending, laboratory testing, and data services to shippers. The company also owns and operates crude oil pipelines and storage facilities; and marine terminals located along coastal waterways that provide distribution, storage, blending, inventory management, and additive injection services for refiners, marketers, traders, and other end users of petroleum products. As of December 31, 2019, it had 9,800-mile refined products pipeline system with 53 terminals, as well as 25 independent terminals; approximately 2,200 miles of crude oil pipelines and storage facilities with an aggregate storage capacity of approximately 35 million barrels; and 6 marine terminals with an aggregate storage capacity of approximately 31 million barrels. Magellan Midstream Partners, L.P. was founded in 2000 and is headquartered in Tulsa, Oklahoma.
Earnings Per Share
As for profitability, Magellan Midstream Partners L.P. Limited Partnership has a trailing twelve months EPS of $4.28.
PE Ratio
Magellan Midstream Partners L.P. Limited Partnership has a trailing twelve months price to earnings ratio of 12.56. Meaning, the purchaser of the share is investing $12.56 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 49.42%.
4. Horace Mann Educators Corporation (HMN)
8% sales growth and 3.82% return on equity
Horace Mann Educators Corporation, together with its subsidiaries, operates as an insurance holding company in the United States. It operates in three segments: Property & Casualty, Life & Retirement, and Supplemental & Group Benefits. The company underwrites and markets personal lines of property and casualty insurance, including personal lines auto and property insurance products; supplemental insurance products, which include cancer, heart, hospital, supplemental disability, and accident coverages; retirement products, such as tax-qualified fixed and variable annuities; and life insurance products comprising whole life and term, as well as indexed universal life insurance products. It also offers student loan solutions, including online student loan management accounts for educators. The company markets its products through its sales force of full-time exclusive agents to K-12 teachers, administrators, and other employees of public schools and their families. Horace Mann Educators Corporation was founded in 1945 and is headquartered in Springfield, Illinois.
Earnings Per Share
As for profitability, Horace Mann Educators Corporation has a trailing twelve months EPS of $3.17.
PE Ratio
Horace Mann Educators Corporation has a trailing twelve months price to earnings ratio of 11.22. Meaning, the purchaser of the share is investing $11.22 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.82%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 28% and a drop 14.4% for the next.
Moving Average
Horace Mann Educators Corporation’s value is below its 50-day moving average of $37.08 and under its 200-day moving average of $37.32.
Yearly Top and Bottom Value
Horace Mann Educators Corporation’s stock is valued at $35.56 at 05:22 EST, way below its 52-week high of $42.95 and way higher than its 52-week low of $32.21.
Revenue Growth
Year-on-year quarterly revenue growth declined by 0.2%, now sitting on 1.35B for the twelve trailing months.
